Apr. 24 at 4:48 PM
$ARDX Posted today: "A key example is Song Life’s work with Ardelyx on Ibsrela, a first-in-class treatment for IBS-C. Partnering closely with the client, the team repositioned the brand by reshaping how patients and healthcare providers understood the category, unlocking a 50 percent increase in prescribing behavior. The result was
$274 million in revenue in 2025, a 73 percent year-over-year growth, with Ardelyx projecting at least 50 percent more in 2026.
“This work reflects a broader trend: identifying overlooked opportunities and applying strategy, creativity, and execution to meaningfully shift trajectories,” says Michael Sanzen, creative founder and managing director. “What’s powerful about stories like Ardelyx isn’t just the outcome, but what they demonstrate about the model. When strategy, creativity, and execution align, you can build momentum where none existed.”
